Company Summary
VIBHA VIBHAVADI MEDICAL CENTER PUBLIC COMPANY LIMITED
Services/Health Care Services
SETWB
CG Report:   
 
  Data as of 28 Jun 2022  
Price (B.) 52 Week High/Low P/E (X) P/BV (X) Paid-up (MB.) Market Cap (MB.) EV (MB.) EBITDA (MB.) EV/EBITDA
2.36 2.82 / 2.10 15.49 2.44 1,357.60 32,039.04 47,944.17 842.94 14.52
News
Date/Time Subject
21 Jun 2022 12:39   Report on the results of the Exercise of VIBHA-W3 (F53-5)
20 Jun 2022 17:16   Report on the results of the Exercise of VIBHA-W3 (F53-5)
16 Jun 2022 12:52   Report on the results of the Exercise of VIBHA-W3 (F53-5)
15 Jun 2022 17:17   Report on the results of the Exercise of VIBHA-W3 (F53-5)
13 Jun 2022 17:05   Shareholders meeting's resolution
more

Company Profile
Address 51/3 NGAMWONGWAN RD., LATYAO, JATUJAK Bangkok 10900
Telephone 0-2579-9680-4, 0-2561-1258-67, 0-2941-2800
Fax 0-2561-1466, 0-2561-1462
URL http://www.vibhavadi.com
Establish Date 01/3/1986 Listed Date 26/03/1992
IPO Price (Baht) 31.00 @Par10.00 Baht
IPO Financial Advisory
  • MEC FAR EAST INTERNATIONAL PUBLIC COMPANY LIMITED
    		•
    Par 0.10 Baht
    Last Par Change Old 1.00 : New 0.10 @ 22/05/2015

    Business
    Hotpital

    Free Float 22 Mar 2022 19 Mar 2021
    % /Shareholders
    29.88% 13,949 33.40% 13,189
    Foreign Shareholders 0.58% (As of 28/06/2022) Foreign Limit 40.00%
    NVDR Shareholders  0.93% (As of 28/06/2022)
    5 Yr Price Performance (Adjusted Price)
    Price Performance (Adjusted Price) Compare to Stock (%) Compare to Sector (%) Compare to Market (%)
    5 Days -0.84 -1.99 -2.08
    20 Days -8.53 -6.16 -5.99
    60 Days -4.84 -4.70 0.52
    120 Days -11.28 -20.54 -8.66
    YTD -10.61 -19.98 -7.07
    P/E (X) 15.49 20.55 18.78
    P/BV (X) 2.44 4.18 1.67
    Turnover Ratio (%) 0.01 0.19 0.92

    Top 10 Major Shareholders(@17 Jun 2022) Share %
    1. บริษัท เอฟแอนด์เอส 79 จำกัด 2,083,909,966 15.35
    2. MR. CHAISITH VIRIYAMETTAKUL 2,037,000,000 15.00
    3. บริษัท สินแพทย์ จำกัด 1,199,859,166 8.84
    4. บริษัท โรงพยาบาลรามคำแหง จำกัด (มหาชน) 962,605,200 7.09
    5. บริษัท โรงพยาบาลเจ้าพระยา จำกัด (มหาชน) 804,334,195 5.92
    6. MR. PISUTH VIRIYAMETTAKUL 584,900,000 4.31
    7. บริษัท โรงพยาบาลวิภาราม จำกัด 564,043,133 4.15
    8. MR. PHITJIT WIRIYAMETTAKUL 473,000,000 3.48
    9. นายแพทย์ เอื้อชาติ กาญจนพิทักษ์ 174,802,916 1.29
    10. MR. PHICHIT WIRIYAMETTAKUL 171,000,000 1.26

    Management Position
    1. Mr. NIKOM WAIRATPANIJ CHAIRMAN OF THE BOARD DIRECTOR / INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    2. Mr. CHAISITH VIRIYAMETTAKUL CHAIRMAN OF EXECUTIVE DIRECTOR / DIRECTOR
    3. Mr. PHIJIT WIRIYAMETTAKUL MANAGING DIRECTOR / DIRECTOR
    4. Mr. CHAMNAN CHANAPAI DIRECTOR
    5. Mr. PONGPAT PATANAVANICH DIRECTOR
    6. Miss RUKKAGEE KANJANAPITAK DIRECTOR
    7. Mrs. BAVORNPHAN RATHPRASERT DIRECTOR
    8. Mr. SITTHI PANUPATTANAPONG DIRECTOR
    9. Mrs. YADA PUTTHKAYON DIRECTOR
    10. Mr. PRAMUK UNACHAK DIRECTOR
    11. Mr. PITCHAYA SOMBURANASIN DIRECTOR
    12. GEN. BOONLOET CHUNTARAPAS INDEPENDENT DIRECTOR
    13. Mr. CHAINARIN SAIRUNGSRI INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    14. Mr. SIROTE SWASDIPANICH INDEPENDENT DIRECTOR / CHAIRMAN OF THE AUDIT COMMITTEE
    15. Mr. PRASERT SRIURANPONG INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    Accumulated: Turnover Ratio, Value Trade/Day
    Statistics YTD
    28 Jun 2022    		 2021
    30 Dec 2021    		 2020
    30 Dec 2020
    Listed share (M.) 13,575.87  13,575.87  13,575.87 
    Market Cap (MB.) 32,039.04  35,840.29  19,956.52 
    Price (B./share) 2.36  2.64  1.47 
    BVPS (B./Share) 0.97  0.75  0.57 
    P/BV (X) 2.44  3.50  2.60 
    P/E (X) 15.49  24.95  67.71 
    Turnover Ratio (%) 15.78  68.02  7.94 
    Value Trade/Day (MB.) 46.92  85.83  6.80 
    Beta 0.31  0.32  0.56 
     
    Rate of Return YTD  2021  2020 
    Price Change (%) -10.61  79.59  -17.88 
    Dividend Yield (%) 2.12  1.52  2.99 
    Payout Ratio 0.33  0.38  2.03 
    Dividend Policy Not less than 80% of net profits after deducting legal reserves and other reserves (if any)

    Dividend
    Operation Period Dividend/Share Unit Payment Date Type
    01 Jan 2021 - 31 Dec 2021 0.05 Baht 25 May 2022 Cash
    01 Jan 2020 - 31 Dec 2020 0.04 Baht 24 May 2021 Cash
    01 Jan 2019 - 31 Dec 2019 0.045 Baht 27 May 2020 Cash
     
    Auditor
    (Effective Until 31/12/2022)
    MR. PERADATE PONGSATHIANSAK/DHARMNITI AUDITING CO., LTD.
    MR. THANAWUT PIBOONSAWAT/DHARMNITI AUDITING CO., LTD.
    MR. SUWAT MANEEKANOKSAKUL/DHARMNITI AUDITING CO., LTD.
    MISS SORAYA TINTASUWAN/DHARMNITI AUDITING CO., LTD.
    Miss POTJANARAT SIRIPIPAT/DHARMNITI AUDITING CO., LTD.
    Miss ROONGNAPHA SAENGCHAN/DHARMNITI AUDITING CO., LTD.
    Miss TECHINEE PORNPENPOB/DHARMNITI AUDITING CO., LTD.
    		F/S Year ended 31/12
    Latest Type of Report Unqualified opinion with an emphasis of matters
    Financial Data
    Statement of Financial Position (MB.) 3M/2022 
    (01/01/22 
    -31/03/22)     		 3M/2021 
    (01/01/21 
    -31/03/21)     		 2021 
    (01/01/21 
    -31/12/21)     		 2020 
    (01/01/20 
    -31/12/20)     		 2019 
    (01/01/19 
    -31/12/19) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Cash And Cash Equivalents 466.98 589.22 511.79 338.29 602.86
    A/R Net 1,136.65 734.52 982.77 639.66 592.60
    Inventories 206.58 161.58 182.44 164.93 174.56
    Current Assets 3,199.99 1,975.98 2,965.73 1,521.33 1,718.79
    PP&E Net 8,566.83 8,133.04 8,558.63 7,970.09 7,024.74
    Non-Current Assets 26,323.99 20,406.33 25,460.94 19,653.68 17,911.06
    Total Assets 29,523.98 22,382.31 28,426.67 21,175.02 19,629.85
    OD 3,700.78 2,875.47 3,821.51 2,605.90 2,677.94
    A/P Net 546.96 374.04 552.77 376.94 431.45
    Current portion of LT 1,215.88 1,140.04 1,345.08 1,065.16 843.18
    Current Liabilities 7,064.98 5,559.30 7,374.38 5,304.90 5,359.02
    Non-Current Liabilities 6,095.89 5,450.32 5,795.71 5,136.10 3,899.17
    Total Liabilities 13,160.87 11,009.62 13,170.09 10,441.00 9,258.19
    Authorized Capital 1,493.91 1,493.91 1,493.91 1,493.91 1,493.78
    Paid-Up Capital 1,357.59 1,357.59 1,357.59 1,357.59 1,326.46
    Premium (Discount) on Share Capital 2,718.14 2,718.14 2,718.14 2,718.14 2,438.33
    Retained Earnings (Deficit) 4,333.19 2,775.72 3,878.48 2,598.52 2,614.08
    Treasury Stock - - - - -
    Shares Of The Company Held By Subsidiaries - - - - -
    Other Components Of Equity 4,742.97 1,919.23 4,230.06 1,496.41 1,409.71
     - Surplus (Deficits) - - - - -
    Shareholders' Equity 13,151.88 8,770.68 12,184.26 8,170.65 7,788.59
    Minority Interest 3,211.23 2,602.01 3,072.31 2,563.37 2,583.08
    more
    Statement of Comprehensive Income (MB.) 3M/2022 
    (01/01/22 
    -31/03/22)     		 3M/2021 
    (01/01/21 
    -31/03/21)     		 2021 
    (01/01/21 
    -31/12/21)     		 2020 
    (01/01/20 
    -31/12/20)     		 2019 
    (01/01/19 
    -31/12/19) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Revenue From Operations 2,303.60 1,598.50 7,419.51 6,024.45 6,545.89
    Other Income 26.83 25.38 111.90 121.71 116.16
    Total Revenues 2,395.56 1,679.43 7,873.84 6,338.25 6,872.48
    Costs 1,532.01 1,125.34 5,218.86 4,485.88 4,778.58
    Selling And Administrative Expenses 269.34 222.67 946.31 925.04 953.47
    Total Cost And Expenses 1,801.35 1,348.01 6,199.70 5,410.92 5,732.05
    EBITDA 842.94 438.84 2,896.83 1,303.67 1,813.73
    Depre. & Amor. 160.53 108.18 501.00 438.69 413.38
    EBIT 682.41 330.66 2,395.83 864.98 1,400.35
    Net Profit : Owners Of The Parent 454.71 191.90 1,805.05 449.80 809.05
    EPS (B.) 0.03 0.01 0.13 0.03 0.06
    more
    Statement of Cash Flow (MB.) 3M/2022 
    (01/01/22 
    -31/03/22)     		 3M/2021 
    (01/01/21 
    -31/03/21)     		 2021 
    (01/01/21 
    -31/12/21)     		 2020 
    (01/01/20 
    -31/12/20)     		 2019 
    (01/01/19 
    -31/12/19) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Operating Cash Flow 430.99 396.07 1,671.76 1,094.74 1,526.56
    Investing Cash Flow -332.28 -513.44 -1,928.65 -1,669.28 -3,087.83
    Financing Cash Flow -143.52 368.30 430.39 309.98 1,857.01
    Net Cash Flow -44.81 250.93 173.49 -264.56 295.73
    more
    Annualized: ROE, ROA
    Ratios 3M/2022  3M/2021  2021  2020 
    Current Ratio (X) 0.45 0.36 0.40 0.29
    ROE (%) 18.87 6.03 17.74 5.64
    ROA (%) 10.59 4.26 9.66 4.24
    D/E (X) 0.80 0.97 0.86 0.97
    Total Asset Turnover (X) 0.33 0.30 0.32 0.31
    Gross Profit Margin (%) 33.50 29.60 29.66 25.54
    EBIT Margin (%) 28.49 19.69 30.43 13.65
    Net Profit Margin (%) 21.98 13.90 24.78 8.50

    Information only PP, PO, XR and XD
    Capital Movement (Last 3 Year)
    Date CA Type Changed paid up share Paid up share Par
    No Information Found

    Growth Rate (%) 3M/2022  3M/2021  2021  2020 
    Sales Growth 44.11 -2.38 23.16 -7.97
    COGs Growth 36.14 -4.86 16.34 -6.13
    Total Revenue Growth 42.64 -1.55 24.23 -7.77
    Total Expense Growth 33.63 -5.80 14.58 -5.60
    Net Profit Growth 136.95 27.04 301.30 -44.40

    Annualized
    Cash Cycle 3M/2022  3M/2021  2021  2020 
    A/R Turnover (Times) 8.68 9.34 9.15 9.78
    Avg. Collection Period (Days) 42.03 39.09 39.91 37.33
    Inventory Turnover (Times) 30.56 25.12 30.05 26.43
    Avg. Inventory Period (Days) 11.94 14.53 12.15 13.81
    A/P Turnover (Times) 15.46 12.06 13.46 11.10
    Avg. Payment Period (Days) 23.61 30.26 27.11 32.89
    Cash Cycle (Days) 30.36 23.36 24.94 18.25


    Trading Sign (Latest)
    Trading Alert Posted Date Lifted Date
    No Information Found

    Market Alert (Latest)
    No Information Found
    more

    Only Preferred Share and Warrants
    Other Securities
    Securities Name -

    Remark - Calculated from adjusted price
      - Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
      - The information is quarterly updated within 7 business days after the new financial statement is submitted.
      -
         		 Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.
    Source: www.set.or.th (Copyright © The Stock Exchange of Thailand)
    The materials and information on this site are provided for informative and educational purpose only, and do not constitute or form a part of any advice or recommendation regarding any securities. The Stock Exchange of Thailand has no responsibility for the accuracy, suitability and completeness of any information, materials, statements, figures, reports or opinions provided, and has no responsibility for any losses and damages in any cases. In case you have any inquiries or clarification regarding this summary, please directly contact the listed company who made this summary.